Sabinsa gains first approval for ANVISA’s IN28 in Brazil for C3 Reduct

Published: 17-Jan-2024 Featured companies: Sabinsa
Ingredients

This approval allows introduction and commercialization of C3 Reduct, most active metabolite of curcumin, in food and supplements in Brazil

Sabinsa, the multi-national health science company founded 35 years ago by Dr. Muhammed Majeed, announces that Curcumin C3 Reduct® has been approved by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list. This approval allows introduction and commercialization of C3 Reduct, most active metabolite of curcumin, in food and supplements in Brazil. Approval is based on a dossier submitted to ANVISA detailing safety and efficacy of a product. C3 Reduct is the only Tetrahydrocurcuminoids approved in this market. C3 Reduct was given approval at dosage of 120mg/day.

Curcumin C 3 Reduct, Sabinsa’s patented and clinically safe 95% tetrahydrocurcuminoids, is the result of the company’s research into metabolites of curcuminoids that have unraveled the role of tetrahydrocurcuminoids as not only the major metabolites but also pharmacologically superior to curcuminoids themselves. It is not the curcumin, but its metabolite, tetrahydrocurcumin (THC), which is responsible for its biological function in the body.

Curcumin C 3 Reduct, tetrahydrocurcuminoids (THCs), the cascading antioxidants and the major metabolites of Curcuminoids, are the colorless hydrogenated compounds derived from Sabinsa’s Curcumin C 3 Complex® curcuminoids: curcumin, demethoxycurcumin and bisdemethoxycurcumin, of which curcumin is the main phenolic compound. As a cascading antioxidant, in comparison to a standalone antioxidant, Curcumin C 3 Reduct will act as an antioxidant for a longer time and show cumulatively stronger activity. With higher bioavailability in the gut compared to parent curcuminoids, Curcumin C 3 Reduct can be delivered in a smaller tablet or capsule.

Sabinsa VP Scientific Affairs Dr. Anurag Pande, who spearheaded the team for submission to ANVISA, said “Many congratulations to our Sabinsa Brazil team for their first approval. This approval of C3 Reduct marks a significant milestone in the supplement market in Brazil, ushering in the era of Next-Generation of Curcuminoids.”

“Approval of C3 Reduct by ANVISA on the IN28 list is a testament to the science that Sabinsa has created on Curcumin metabolites,” remarked Dr. Majeed. “This is our first approval in the Brazilian market, with more to follow.”

Sabinsa holds patents on Curcumin C3 Reduct in multiple other countries throughout the world.

Featured companies

Sami-Sabinsa Group, founded in 1988, is an ISO certified manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and speciality fine chemicals. Sabinsa’s...
See more

You may also like

Ingredients

Fire up your natural energy booster through Sabinsa’s C3 Reduct

Read more
C3 Reduct is more potent than curcumin in activating cellular energy balance. It activates the Adenosine monophosphate-activated protein kinase (AMPK) and helps to reduce excess glucose and fats, by burning them for energy

Trending Articles

  1. Activating autophagy: a nutritional strategy with longevity applications As consumers prioritise their healthspan as opposed to their lifespan, the targeted use of dietary spermidine to stimulate autophagy is emerging as a promising healthy ageing approach
  2. ADM’s gut health probiotic approved by the Chinese NHC DE111, ADM’s proprietary spore-forming probiotic, has been certified by the National Health Commission in China
  3. dsm-firmenich and Lallemand partner to launch early life synbiotic solutions The solution will contain a combination of human milk oligosaccharides (HMOs) that will mimic breast milk, boosting the infant immune system and gut microbiome
  4. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet equally powerful partnership is that of vitamins D3 and K2
  5. Roquette Beauté appoints Barentz as preferred US distribution Partner Roquette Beauté and Barentz International will collaborate to expand cosmetics ingredients distribution in the US

Relevant companies

See more

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Ingredients

Fire up your natural energy booster through Sabinsa’s C3 Reduct

C3 Reduct is more potent than curcumin in activating cellular energy balance. It activates the Adenosine monophosphate-activated protein kinase (AMPK) and helps to reduce excess glucose and fats, by burning them for energy
Ingredients

Sabinsa Nanjing expands into new facility in Nanjing, China

Sabinsa, the multinational health science company founded by Dr Muhammed Majeed 35 years ago, will begin the new year by relocating the Sabinsa Nanjing Biotechnology Company corporate office to a new location in Nanjing, China
Ingredients

Clinical study published on Sabinsa’s Shagandha Ashwagandha shows benefits for stress management in healthy adults

Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, announces the most recent clinical study on its branded 2.5% USP grade Ashwagandha root ingredient: Shagandha
Ingredients

Unlocking the power of stilbenes for weight management

Clinical studies suggest that Cirpusins may support weight management efforts in individuals with higher body weights
Ingredients

Sabinsa to showcase 35 years of category leading ingredients at SupplySide West

Sabinsa, the multinational health science company founded 35 years ago by Dr Muhammed Majeed, will feature the research and benefits of the company’s category leading science-supported ingredient products and long history of sustainability at SupplySide West
Ingredients

Sabinsa celebrates 35th anniversary

From a humble beginning in the US in 1988 as a company importing generic drugs, the company has long since emerged as an industry leader
Ingredients

C3 Reduct - The first to deliver curcumin as metabolites

Sabinsa’s C3 Reduct (registered trademark) is the only EFSA-approved reductive metabolites of curcuminoids on the market. Direct assimilation in the body as beneficial, bioavailable metabolites enables product formulators to appeal to consumers looking for proven, science-backed products. Indeed, consumers are increasingly looking for natural, functional preventive solutions that can better support their efforts to keep fit and healthy.
Subscribe now